Autopsy report · NCT02154243
An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty
Cause of deathNo reason given
Life of this trial
- Ran for about 7 months before it stopped.
- 13 participants enrolled.
- Results were posted on the registry 2 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Hospital for Special Surgery, New York
- Sponsor type
- University, hospital or other
- Conditions
- Orthostatic Hypotension
- Interventions
- Midodrine; Intravenous fluid bolus
- Participants
- 13
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.